Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 34 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 10611760

    Therapeutic compounds as inhibitors of the orexin-1 receptor

    C4X Discovery Limited · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted
  2. US 10597382

    Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted
  3. US 10590090

    2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors

    Revolution Medicines, Inc. · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  4. US 10590121

    Kinase inhibitors and methods for making and using

    Rigel Pharmaceuticals, Inc. · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  5. US 10590074

    Potent and selective inhibitors of monoamine transporters; method of making; and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  6. US 10590082

    N-(5-((aryl or heteroaryl)methyloxy)pentyl)-substituted iminosugars as inhibitors of glucosylceramide synthase

    ACADEMISCH MEDISCH CENTRUM · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  7. US 10588897

    Piericidin bacterial inhibitors

    The Regents of the University of California · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  8. US 10584132

    SHMT inhibitors

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted
  9. US 10584115

    Substituted pyridine and pyrazine BMI-1 inhibitors

    PTC THERAPEUTICS, INC. · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted
  10. US 10576107

    Methods of treating joint diseases, disorders, and conditions with tissue inhibitors of matrix metalloproteinases

    Prime Merger Sub, LLC · Granted Mar 3, 2020 · Expires Feb 27, 2040

    granted
  11. US 10577349

    Quinolinones as inhibitors of translation initiation complex

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 3, 2020 · Expires Feb 27, 2040

    granted
  12. US 10576145

    CD200 inhibitors and methods of use thereof

    Regents of the University of Minnesota · Granted Mar 3, 2020 · Expires Feb 27, 2040

    granted
  13. US 10568888

    Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

    VTV THERAPEUTICS LLC · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  14. US 10570153

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  15. US 10570140

    Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  16. US 10570120

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  17. US 10562850

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  18. US 10556892

    Piperazinyl methanone NAAA inhibitors

    The Regents of the University of California · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  19. US 10556897

    Protein kinase inhibitors

    Princeton Drug Discovery, Inc · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  20. US 10548889

    Compositions of CXCR4 inhibitors and methods of preparation and use

    X4 Pharmaceuticals, Inc. · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted
  21. US 10550118

    JAK inhibitors containing a 4-membered heterocyclic amide

    Theravance Biopharma R&D IP, LLC · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted
  22. US 10543221

    Beta-lactamase inhibitors, formulations, and uses thereof

    The Regents of the University of California · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted
  23. US 10538513

    Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted
  24. US 10537535

    Histone deacetylase inhibitors

    The Regents of the University of California · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted